Simultaneous imaging and therapy using epitope-specific anti-epidermal growth factor receptor (egfr) antibody conjugates

HIGHLIGHTS

• who: Anjong Florence Tikum and colleagues from the Department of Medical Imaging, College of Medicine, University of Saskatchewan, Saskatoon, SK S N , Canada have published the paper: Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates, in the Journal: Pharmaceutics 2022, 1917 of /2022/
• what: This study shows for the first time the use of an anti-EGFR probe 89Zr-matuzumab and an anti-EGFR therapeutic agent nimotuzumabPEG6-DM1 for simultaneous epitope-specific imaging and therapy of a receptor overex- 13 of 17
• how: Flow data were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.